Fonar Corp (FONR, Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2018. Fonar Corp is engaged in the research, development, production and marketing of medical scanning equipment. The Company operates in two segments manufacturing and servicing of medical equipment and management of diagnostic imaging centers. Fonar Corp has a market cap of $158.775 million; its shares were traded at around $24.75 with a P/E ratio of 7.98 and P/S ratio of 1.94. Fonar Corp had annual average EBITDA growth of 17.00% over the past five years.
For the last quarter Fonar Corp reported a revenue of $21.0 million, compared with the revenue of $20.89 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $81.5 million, an increase of 4.5% from last year. For the last five years Fonar Corp had an average revenue growth rate of 8.9% a year.
The reported diluted earnings per share was $3.1 for the year, an increase of 6.2% from previous year. Over the last five years Fonar Corp had an EPS growth rate of 19.5% a year. The Fonar Corp had a decent operating margin of 24.15%, compared with the operating margin of 24.47% a year before. The 10-year historical median operating margin of Fonar Corp is 16.65%. The profitability rank of the company is 8 (out of 10).
At the end of the fiscal year, Fonar Corp has the cash and cash equivalents of $19.7 million, compared with $10.1 million in the previous year. The long term debt was $0.31 million, compared with $0.34 million in the previous year. The interest coverage to the debt is at a comfortable level of 123. Fonar Corp has a financial strength rank of 8 (out of 10).
At the current stock price of $24.75, Fonar Corp is traded at 129% premium to its historical median P/S valuation band of $10.81. The P/S ratio of the stock is 1.94, while the historical median P/S ratio is 0.85. The stock lost 15.38% during the past 12 months.
For the complete 20-year historical financial data of FONR, click here.
